Commit 55aab94e authored by chloe's avatar chloe

Update portfolioPage “portfolioPage”

parent 88233da5
......@@ -1306,4 +1306,61 @@ portfolio:
type: 医疗健康
website: https://www.doublerainbowbio.com/
description: 双虹生物科技公司致力于开发变革性生物技术,从自然界释放化学的力量以造福人们的生活。植根于对植物和其他生物体中次生代谢系统的机理理解,我们设计了新颖的生物合成平台策略,为获得具有药用或其他工业意义的高价值天然产物提供可持续的途径。源于自然代谢系统进化原理的启发,我们进一步扩展了超出自然范围的化学空间。利用从世界传统草药中提炼出的古老智慧和现代疾病生物学的深厚知识库,我们开发以自然为灵感的新药,用于治疗人类疾病。
- descriptionEN: Wallaby Medical is an exciting, rapidly growing medical device
company focused on developing and commercializing medical device products
for treating stroke. Our first product, the Wallaby Avenir Coil System is
a technically differentiated neuro embolic coil system for treating
intracranial aneurysms and other neurovascular abnormalities. Avenir is
now FDA 510K cleared, CE marked, and Japan PMDA approved and is selling in
over 10 countries. Wallaby has several other advanced products currently
under development. Wallaby Medical was established in 2015 and now has
over 90 employees located in our offices in Laguna Hills, California and
Shanghai, China. We're a high-growth, customer-focused company with an
entrepreneurial spirit. We are producing some of the most reliable and
technologically advanced products supported by proven clinical data.
logo2: /static/img/wobilogo.png
sinceDate: 2021-05-10T12:50:29.738Z
logo: /static/img/wobilogo.png
name: 沃比医疗
nameEN: Wallaby Medical
type: 医疗健康
website: http://www.wallabymedical.com/index.html
description: 沃比医疗是一家专注于神经介入领域的医疗科技公司,致力于成为全球挽救中风患者生命最多的医疗科技公司。公司创建于2016年7月,公司总部和生产基地位于上海医谷,美国设有研发中心。公司主要研发和生产国际高端血管疾病治疗的创新产品。沃比医疗拥有一支专业的神经介入领域研发队伍,美国研发团队和中国技术团队携手一同研发众多突破性的神经介入产品,现已开展多个产品的研发及临床实验工作,在国际、国内形成数十项专利;2018年沃比医疗成为第一个获得脑神经介入治疗产品FDA认证的中国公司,并在2019年初开始正式步入国际市场。产品已经远销美国、德国、英国、智利等10多个国家。
- descriptionEN: Qitan Technology is dedicated to researching, developing,
manufacturing and applying nanopore genome sequencers and reagents to
match an increasing demand for genome sequencing from life technology
field. Qitan has successfully developed and released China’s first
original nanopore genome sequencer. Founded by a top-notch team of
scientists, Qitan boasts a world-class inter-disciplinary R&D team, which
has achieved a collection of intellectual properties and established its
own nanopore genome sequencing technology. Representing a revolutionary
fourth-generation technology, a nanopore genome sequencer can directly
sequence single molecules without PCR. Not only is its read-length longer,
it is also faster, smaller in size, easier to use in a wider range of
applications, and at a lower price.
logo2: /static/img/qitanlogo.png
sinceDate: 2020-05-08T12:51:31.964Z
logo: /static/img/qitanlogo.png
name: 齐碳科技
nameEN: Qitan Technology
type: 医疗健康
website: http://www.qitantech.com/
description: 齐碳科技创立于2016年,致力于纳米孔基因测序仪及配套试剂耗材的自主研发、制造与应用,以满足生命健康领域对基因测序日益增长的需求。齐碳科技已经推出中国第一台纳米孔基因测序仪,填补国内空白。齐碳科技由顶尖创始合伙人领衔,组建了国际一流的跨学科研发团队,全面掌握纳米孔单分子基因测序技术,拥有完善的知识产权布局。纳米孔基因测序技术属于最前沿的第四代基因测序技术,技术原理创新,具备多项优势。它具备单分子测序能力,测序过程无需进行PCR扩增,读长更长、速度更快、成本更低、仪器小巧便携,方便操作,应用场景也更为丰富。
- descriptionEN: Founded in July 2020, Westlake Omics (wOmics) is a company
focused on using mass spectrometry and other high-throughput molecular
quantitative technologies to generate omics data , and applying AI
technology to analyze biomedical big data. The company is dedicated to
developing advanced mass spectrometry-based proteomics techniques for
minute amount of clinical specimens. wOmics's persistent efforts have been
propped by its breakthroughs in auxiliary clinical diagnostics and drug
discovery empowered by AI and omics big data, facilitating precision
medicine.
logo2: /static/img/xihuoumilogo.png
sinceDate: 2021-02-25T12:52:22.407Z
logo: /static/img/xihuoumilogo.png
name: 西湖欧米
nameEN: Westlake Omics
type: 医疗健康
website: https://www.westlakeomics.com/index/index/index/lang/cn
description: 西湖欧米创立于2020年7月,是一家专注于使用质谱等高通量分子定量技术产生组学数据,并使用AI技术分析生物医学大数据助力精准医疗的创新型公司。致力于不断优化基于质谱的微量生物样本蛋白质组分析技术,开发AI赋能的、基于组学大数据的临床辅助诊断新方法和新药开发,助力精准医学。
---
Markdown is supported
0% or
You are about to add 0 people to the discussion. Proceed with caution.
Finish editing this message first!
Please register or to comment